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Cysteine proteasesBrugia malayi, a parasitic nematode that causes lymphatic ﬁlariasis, harbors endosymbiotic intracellular
bacteria, Wolbachia, that are required for the development and reproduction of the worm. The essential
nature of this endosymbiosis led to the development of anti-Wolbachia chemotherapeutic approaches for
the treatment of human ﬁlarial infections. Our study is aimed at identifying speciﬁc proteins that play a
critical role in this endosymbiotic relationship leading to the identiﬁcation of potential targets in the
adult worms. Filarial cysteine proteases are known to be involved in molting and embryogenesis,
processes shown to also be Wolbachia dependent. Based on the observation that cysteine protease tran-
scripts are differentially regulated in response to tetracycline treatment, we focused on deﬁning their role
in symbiosis. We observe a bimodal regulation pattern of transcripts encoding cysteine proteases when
in vitro tetracycline treated worms were examined. Using tetracycline-treated infertile female worms and
puriﬁed embryos we established that the ﬁrst peak of the bimodal pattern corresponds to embryonic
transcripts while the second takes place within the hypodermis of the adult worms. Localization studies
of the native proteins corresponding to Bm-cpl-3 and Bm-cpl-6 indicate that they are present in the area
surrounding Wolbachia, and, in some cases, the proteins appear localized within the bacteria. Both pro-
teins were also found in the inner bodies of microﬁlariae. The possible role of these cysteine proteases
during development and endosymbiosis was further characterized using RNAi. Reduction in Bm-cpl-3
and Bm-cpl-6 transcript levels was accompanied by hindered microﬁlarial development and release,
and reduced Wolbachia DNA levels, making these enzymes strong drug target candidates.
 2014 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Filarial parasites are responsible each year for millions of
human infections worldwide, causing chronic diseases that include
lymphatic ﬁlariasis (elephantiasis) due to Brugia malayi orWuchereria bancrofti infection, and onchocerciasis (river blindness)
as a result of infection by Onchocerca volvulus (Lustigman et al.,
2012). Present international control programs are focused on the
reduction of transmission with the ultimate goal of eliminating
these diseases. They are, however, almost universally based on a
single strategy: the mass administration of microﬁlaricidal drugs
(Molyneux and Taylor, 2001; Molyneux et al., 2003; Chu et al.,
2010; Taylor et al., 2010; Hoerauf et al., 2011). Importantly, treat-
ment of ﬁlarial infections in humans is still suboptimal due to a
lack of macroﬁlaricidal drugs (i.e. drugs that can kill adult worms),
and no vaccines are yet available to prevent new infections
(Hoerauf et al., 2011; Lustigman et al., 2012; Prichard et al.,
2012). Additional research is critically needed to discover novel
drug targets and to develop a new generation of drugs with macro-
ﬁlaricidal effects.
Many ﬁlarial species harbor an endosymbiotic bacterium of the
genus Wolbachia. A recent investigation of Wolbachia distribution
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genera have shown that 37% of them harborWolbachia (Ferri et al.,
2011). In ﬁlarial nematodes, Wolbachia appear to have evolved
towards a mutualistic symbiosis. Genomic information for B.
malayi and its endosymbiont Wolbachia have enabled us to better
understand this co-dependency (Foster et al., 2005a; Ghedin
et al., 2007; Slatko et al., 2010). As the endosymbiont has limited
biosynthetic capabilities, it is highly plausible that the host supple-
ments Wolbachia with amino acids required for growth (Foster
et al., 2005a,b). Conversely,Wolbachia appears to supply the ﬁlarial
host with riboﬂavin, ﬂavin adenine dinucleotide, nucleotides and
possibly also heme, although the recent genome study of Loa loa,
which does not harbor Wolbachia indicates that this might be
overly inferred (Desjardins et al., 2013). Notably, the endosymbi-
ont appears to be essential for optimal ﬁlarial development in
the deﬁnitive human host, including development of L3 to L4 and
reproduction; as such, it has become a target for the development
of novel chemotherapeutic drugs (Foster et al., 2005a; Slatko et al.,
2010; Johnston et al., 2014; Taylor et al., 2014). Wolbachia appears
to be less important for L1 to L3 development in the intermediate
host (Arumugam et al., 2008). Treatment of humans with antibiot-
ics was shown to have a strong anti-ﬁlarial effect, conﬁrming the
essential role Wolbachia plays in survival and reproduction of the
worm. For example, antibiotic treatment ofW. bancrofti or O. volvu-
lus-infected patients with doxycycline resulted in a long-term
embryostatic effect, sterility of adult female worms with a sus-
tained reduction of microﬁlarial loads (Taylor et al., 2010;
Hoerauf et al., 2011). Notably, this treatment resulted also in slow
death for the adult worms, with the majority of the worms (70% for
onchocerciasis and 90% for LF) dying 2 years after treatment, with
subsequent improvement in the pathological manifestations of
both diseases (Debrah et al., 2006, 2007, 2011; Hoerauf et al.,
2008; Specht et al., 2008, 2009).
To better understand endosymbiosis at the molecular level and
the dependency of B. malayi on its endosymbiont, we analyzed B.
malayi gene expression patterns in response to depletion ofWolba-
chia by tetracycline treatment in vivo (Ghedin et al., 2009). This
study highlighted B. malayi metabolic pathways—including
proteolysis, translation, energy metabolism, and signal transduc-
tion—as being affected by Wolbachia depletion, thus indirectly
implicating them in the endosymbiotic relationship (Ghedin
et al., 2009). Some of the most up-regulated genes encoded
proteins known to be involved in regulating degradation of intra-
cellular proteins, including the cathepsin L-like cysteine proteases
Bm-cpl-3 (Wormbase gene ID WBGene00233004) and Bm-cpl-6
(WBGene00233058). Bm-cpl-3 was up-regulated at day 7
post-treatment while Bm-cpl-6 was up-regulated at day 14 post-
treatment. In comparison, Bm-cpl-4 (WBGene00227937) was
down-regulated 7 and 14 days after depletion of the endosymbiont
with tetracycline (Ghedin et al., 2009). The regulation of the
cathepsin L-like cysteine proteases by tetracycline treatment was
of interest, as it identiﬁed a potential connection between the
essential dependency of the ﬁlarial parasite on Wolbachia and the
known functions of these proteins in the ﬁlarial host (Ghedin
et al., 2009).
Remarkably, the role of Wolbachia during ﬁlarial development,
molting and embryogenesis is similar to the roles attributed to
these proteases in ﬁlarial development (Lustigman et al., 1992,
1996, 2004; Tort et al., 1999; Guiliano et al., 2004; Ford et al.,
2009). In B. malayi, two clade I subfamilies of the cathepsin L- like
cysteine proteases (Bm-CPL) were identiﬁed (Guiliano et al., 2004):
clade group Ia includes Bm-CPL-1, -4 and -5, and clade Ic includes
Bm-CPL-2, -3, -6, -7 and -8. The cathepsin-L like proteases of group
Ia have been studied extensively (Britton and Murray, 2004, 2006;
Guiliano et al., 2004; Ford et al., 2009), and were shown by RNA
interference (RNAi) to be essential for molting of O. volvulus larvae(Lustigman et al., 2004) and B. malayi larvae (Song et al., 2010), as
well as for embryogenesis in B. malayi female worms (Lustigman
et al., 2004; Ford et al., 2009). Electron microscopy analysis of
adult female worms treated with double-strand RNA correspond-
ing to Bm-cpl-5 indicated that the number of Wolbachia in the
hypodermis of the adult worms as well as in microﬁlariae were
much reduced in the RNAi treated worms, as compared to the
untreated controls. In comparison, the number of Wolbachia in
the oocytes and embryos was similar to those of normal worms
(Ghedin et al., 2008). To further understand the possible role of
the ﬁlarial cysteine proteases during symbiosis we focused in
the present study on the group Ic cathepsin-L like proteases, since
expression of Bm-cpl-3 and Bm-cpl-6 is modulated by Wolbachia
depletion (Ghedin et al., 2009) and very little is known about these
proteins.2. Materials and methods
2.1. Treatment with tetracycline of young and adult B. malayi worms
Young (42 days post-infection) and adult female worms
(120 days post-infection) were treated with tetracycline in vitro
in short-term cultures. The parasites were obtained from the
NIH/NIAID Filariasis Research Reagent Resource Center (www.ﬁla-
riasiscenter.org). Worms were washed several times with incom-
plete RPMI-1640 media (Gibco, Grand Island, New York)
containing 100 U/ml streptomycin, 100 lg/ml penicillin, and
0.25 mg/ml of amphotericin-B (Sigma). The young or adult female
worms were cultured in groups of 4 in 2 ml of complete media
(CM; incomplete RPMI 1640 supplemented with 25 mM HEPES
buffer, 2 mM glutamine, and 10% heat-inactivated fetal calf serum)
or with 40 lg/ml tetracycline (Sigma) in CM in 24-well culture
plates (Costar, Cambridge, Massachusetts). The cultured worms
were incubated at 37 C in an atmosphere of 5% CO2 in air. The cul-
ture medium was replaced daily with CM or CM + tetracycline.
Worms were harvested on day 6 or earlier based on the experi-
ment. Each experiment was carried out in triplicate.
The worms and embryos were treated with 40 lg/ml tetracy-
cline as previous studies had demonstrated that this was the min-
imum concentration capable of reducing microﬁlariae release
in vitro by close to 100% (Rao and Well, 2002), and in our previous
study (Ghedin et al., 2009) caused 100% degradation of Wolbachia
without affecting the worms’ motility. Moreover, the concentration
of 40 lg/ml is equivalent to a concentration of 83 lM, which is
well within the range of drug concentrations reported in other
published studies (Rao and Well, 2002).2.2. Treatment with tetracycline of B. malayi embryos
B. malayi adult female worms (500 worms, 120 days post-infec-
tion) were cut into small pieces using a scalpel in approximately
10 ml of complete media (CM; incomplete RPMI 1640 supple-
mented with 25 mM HEPES buffer, 2 mM glutamine, and 10%
heat-inactivated fetal calf serum). One hour of gentle rocking at
room temperature followed by overnight incubation at 37 C
resulted in the release of all embryonic stages. The embryos were
then separated from the cuticles by passing the suspension twice
through a ﬁlter (BD Falcon, 70 lm Nylon, 35-2350). The embryos
were centrifuged for 10 min at 2000 rpm at room temperature
and their number quantiﬁed using the improved Neubauer haem-
ocytometer. Treatment of embryos with tetracycline (40 lg/ml)
was carried out in vitro in 24-well culture plates (Costar,
Cambridge, Massachusetts) for 6 days at 37 C under 5% CO2. Each
well contained 7  105 embryos and the treatment was carried out
in triplicate for each time point.
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B. malayi worms or embryos treated with 40 lg/ml tetracycline
along with their respective controls were snap frozen and crushed
in liquid nitrogen using a mortar and pestle. Crushed samples were
re-suspended in TRIzol reagent (Invitrogen, Carlsbad, CA) and total
RNA was prepared according to the manufacturer’s protocol. RNA
samples were treated with ampliﬁcation grade DNase I (Gibco
BRL, Gaithersburg, MD) to eliminate genomic DNA contamination.
Quantitation of RNA was performed using a NanoDrop 2000
(Thermo Scientiﬁc).
Synthesis of ﬁrst strand complementary DNA (cDNA) was pre-
pared from 1 lg total RNA using the SuperScript™ III First Strand
Synthesis System and random primers followed by treatment with
RNase H-Reverse Transcriptase (Invitrogen, Carlsbad, CA). The
qRT-PCR reaction included 5 ll cDNA template mixed with
12.5 ll SYBR Green/Rox PCR master mix (SABiosciences), 1 ll each
of 5 lM forward and reverse gene-speciﬁc primers in a 25 ll total
reaction volume. The gene-speciﬁc primers used are listed in
Supplementary Table 1. The PCR reaction conditions were 50 C for
2 min, 95 C for 10 min, and 40 cycles for 15 seconds at 95 C, 30 sec-
onds at 60 C and 30 seconds at 72 C (ABI 7300 Real-time PCR sys-
tem). Threshold cycle values were normalized against B. malayi
NADH dehydrogenase subunit 1 (ND1) as the internal control gene.
For qRT-PCR of the related Acanthocheilonema viteae cpl genes,
the speciﬁc primers listed in Supplementary Table 2 were used.
The cDNA samples used for the analyses were from female A. viteae
adult worms recovered from infected Meriones unguiculatus that
were not treated, or treated orally for six weeks with 0.5% (w/v)
tetracycline in drinking water (Strubing et al., 2010). The PCR con-
ditions were as described above for B. malayi, however the thresh-
old cycle values were normalized against the A. viteae actin as the
internal control gene.
To measure the relative expression level of each transcript in
the treated worms or embryos versus their corresponding control
groups, the DDCt method was implemented: DDCt =DCttreated
 DCtcontrol. The DDCt was obtained from subtracting the DCt
value of the control group from that of the tetracycline treated
samples. Finally, gene expression fold change in the tetracycline
treated over control B. malayi worms was determined using the
formula 2DDCt.
2.4. Expression and puriﬁcation of B. malayi Bm-CPL-3 and Bm-CPL-6
proteins
cDNAs corresponding to Bm-CPL-3 and Bm-CPL-6 were ampli-
ﬁed by PCR from female B. malayi total RNA using the following
forward and reverse primer sets: 50-CGGGATCCAATCCACTTAAT-
GAACTGG-30 and 50-CCGCTCGAGTTTGAAGATTGGTACGTTCG-30;
50-CGGGATCCCTAATTTATCAGCAATTC-30 and 50-CCGCTCGAGCATT
GCAGCAAGTGATTCAAG-30, respectively. The 1074bp Bm-cpl-3
and 973bp Bm-cpl-6 products were cloned directly into TOPO TA
plasmid vector (Invitrogen), followed by the subcloning of the spe-
ciﬁc inserts into the pET43 expression vector (Novogen) according
to the manufacturers’ instructions. The ﬁdelity of the cloned PCR
amplicons and their orientation were conﬁrmed by DNA sequenc-
ing. Expression of Bm-CPL-3 and Bm-CPL-6 recombinant proteins
was done through the transformation of the pET43_Bm-cpl-3 and
pET43_Bm-cpl-6 plasmids into BL21 (DE3) Escherichia coli. This
cloning strategy resulted in His-Bm-CPL-3 and His-Bm-CPL-6
fusion proteins, which were puriﬁed, respectively, under natural
and 6 M Urea denaturing conditions using the His Bind Columns
(Novagen) according to the manufacturer’s instructions. Recombi-
nant His-Bm-CPL-6 protein puriﬁed under denaturing condition
was dialyzed (50 mM Tris–HCl, 18 mM NaCl, 1 mM EDTA, pH 7.6)
after puriﬁcation. Both puriﬁed recombinant proteins wereanalyzed by SDS–PAGE. Protein concentration was determined
using NanoDrop 2000 (Thermo Scientiﬁc).
2.5. Production of mouse antibodies against Bm-CPL-3 and Bm-CPL-6
recombinant proteins
A group of ﬁve female BALB/c mice were immunized subcutane-
ously (s.c.) with 30 lg of recombinant His-Bm-CPL-3 or His-
Bm-CPL-6 proteins formulated with the Sigma Adjuvant System,
as recommended by the manufacturer (Sigma–Aldrich, St. Louis,
MO, USA) and under an approved protocol (IACUC protocol #224,
New York Blood Center). Boost immunizations were given on days
14 and 28 post primary immunizations. Blood was collected pre-
immunization and day 7 after last immunization. Pooled serum
was analyzed by western blot. The protein bands of both recombi-
nant proteins, as well as their corresponding native proteins in B.
malayi crude extract, were detected with each of the protein
speciﬁc polyclonal antibodies. There was no recognition of the
recombinant proteins when pre-immunization serum was used
(data not shown).
2.6. Localization of Bm-CPL-3 and Bm-CPL-6 in B. malayi worms by
immunoelectron microscopy
B. malayi female worms were ﬁxed in 0.25% glutaraldehyde in
0.1 M phosphate buffer, pH 7.4 containing 1% sucrose for 60 min
at room temperature and processed for immunoelectron micros-
copy, as described previously (Guiliano et al., 2004). Thin sections
of embedded worms were blocked and probed with mouse anti-
bodies raised against recombinant His-Bm-CPL-3 or His-Bm-CPL-6
(1:10 dilution) followed by 15 nm or 18 nm gold labeled goat
anti-mouse IgG (H + L) (Amersham Biosciences, UK). Pre-immuni-
zation serum was used as the control.
2.7. Phylogenetic analysis of the ﬁlarial CPL family
Orthologous ﬁlarial genes were identiﬁed by BlastP searches
using curated B. malayi gene models against the GenBank nr data-
base limited to ﬁlarial nematodes. Scaffolds encoding A. viteae CPL
family members were downloaded from the 959 nematodes
project page (http://nematodes.org/genomes/acanthocheilonema_
viteae/), and manual gene predictions were generated for ortholo-
gous CPLs. A multiple peptide alignment of ﬁlarial CPLs was gener-
ated using Muscle (v. 3.8.3) (Edgar, 2004). The alignment was then
inspected manually, and peptide sequences with partial or missing
mature regions, or proregions were removed from the analysis. A
character set for phylogenetic analysis was generated using
Gblocks (Talavera and Castresana, 2007), then manually adjusted.
A phylogenetic tree was generated using PhyML (v3.0)
(Guindon and Gascuel, 2003) from 197 characters, using the LG
substitution model, and rates across sites modeled on a discrete
gamma model approximated with four rate categories; 1000
bootstrap replicates were performed. Only nodes with bootstrap
support values above 50% (500) are shown on the tree (Fig. 3).
Clades were determined based on membership of annotated Brugia
CPLs. The tree was rooted on the CPZ clade.2.8. RNA interference (RNAi) treatment of B. malayi adult females
RNAi treatment of B. malayi adult females was carried out by
soaking with siRNA as previously described (Ford et al., 2009) with
few modiﬁcations. For RNA transcription, puriﬁed plasmid DNA
containing Bm-cpl-3 (bp 119-1128) or Bm-cpl-6 (bp 83-1035) cDNA
sequence was ﬁrst ampliﬁed with M13 forward and M13 reverse
primers (Invitrogen). Puriﬁed PCR products were then used for
Fig. 1. Fold changes in mRNA expression of the cathepsin L-like Ia and Ic family (Bm-cpl) members over six days of tetracycline treatment. Adult female B. malayi worms
(120 days post infection) were treated with 40 lg/ml tetracycline for up to six days; experiments were performed in triplicate. Levels of cpl mRNA were compared each day
between the treated and the untreated worms. Fold changes are presented in log scale. Each data point (bullet) represents one independent experiment. The blue line
represents average values of three independent experiments. The cutoff of 2- or 0.5-fold increase or decrease, respectively, are marked by a solid black line. (For interpretation
of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 2. Fold changes in mRNA levels of Bm-cpl genes after tetracycline treatment in egg and embryos (EE), young unfertile female B. malayi worms (42 days post infection) or
fertile adult worms (90 days post infection). Each stage was treated with 40 lg/ml of tetracycline for up to six days. The Bm-cpl genes analyzed belong to the Ic (Bm-cpl-3 and
Bm-cpl-6) and the Ia (Bm-cpl-4 and Bm-cpl-5) cathepsin L-like families. The mRNA levels of the treated embryos or young and adult worms were compared to untreated
control groups cultured for one and six days with or without tetracycline, respectively. Each column represents the mean fold change per treatment group based on three
biological replicas and the error bar is the SD. The cut offs of 2- fold increase and decrease are marked by solid black lines.
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RNA polymerase and the MEGAscript high yield transcription kit
(Ambion Inc., Austin, TX). Integrity of dsRNA was conﬁrmed by
standard agarose gel electrophoresis. The siRNA corresponding to
the speciﬁc target was produced by digesting transcribed dsRNAwith RNase III (Ambion) according to the manufacturer’s instruc-
tions. Undigested and partially RNase III digested material was
removed using a siRNA puriﬁcation unit (Ambion). The siRNA
was quantiﬁed by measuring absorbance and the concentration
calculated according to the manufacturer’s instructions.
Fig. 3. PhyML maximum likelihood tree of ﬁlarial CPLs and CPZ. Bootstrap support values are shown at nodes. Taxon names are abbreviated to simplify the ﬁgure. Full names
are as follows: Acanthocheilonema viteae (Av), Brugia malayi (Bm), Brugia pahangi (Bp), Diroﬁlaria immitis (Di), Loa loa (Ll), Onchocerca volvulus (Ov),Wuchereria bancrofti (Wb).
Grey boxes surrounding clades indicate CPL membership within each of these clades, brackets on the right edge of the ﬁgure show CPL clade nomenclature described in
Guiliano et al. (2004). All sequences with the exception of A. viteae sequences were downloaded from Genbank, and corresponding Genbank accessions are shown with
abbreviated names. Brugia malayi CPLs are labeled according to their predicted clade. Genbank accessions for these are as follows: Bm_CPL1 (AAT07060), Bm_CPL2
(BAC24764), Bm_CPL3 (BAC24765), Bm_CPL4 (AAT07057), Bm_CPL5 (AAT07058), Bm_CPL6 (AAT07055.1), Bm_CPL7 (AAT07056), Bm_CPL8 (AAT07054), Bm_cathepsinlikeA
(AAK16513.1), Bm_cathepsinlikeB (XP_001896823.1). A. viteae coding sequences were predicted based on the A. viteae assembly (May 2012). Contigs on which these were
predicted are as follows: Av_CPL1 (nAv.1.0.scaf01660), Av_CPL3 (nAv.1.0.scaf04999), Av_CPL6 (nAv.1.0.scaf03681), Av_CPL8 (nAV00022).
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post infection in RPMI-1640 (Invitrogen, Carlsbad, CA, USA) plus
1% glucose and 1X antibiotic-antimycotic solution (Sigma–Aldrich,
St Louis, MO, USA) at 37 C in a 5% CO2 incubator, and the ﬁtness of
individual worms and their microﬁlaria release was scored. The
highly viable and motile individual worms were then transferred
individually into 48-well plates containing culture medium with
10% heat-inactivated fetal calf serum and 5 lM Bm-cpl-3 or Bm-
cpl-6 siRNA. The negative controls included: culture medium con-
taining RNA storage buffer (medium control) and siRNA corre-
sponding to an O. volvulus intronic sequence, Ov-cpz-int2
(negative control).The following phenotypic and molecular outcomes were mea-
sured after 48 h and 96 h in culture: (1) release ofmicroﬁlariae from
individual female worms after siRNAi treatment in comparison to
medium and RNAi negative control groups (9-10 worms per treat-
ment); (2) embryogram (2–3 worms per treatment group), analysis
of the stages of uterineembryonicdevelopment (eggs, embryos, pre-
microﬁlariae, stretched microﬁlariae); (3) Bm-cpl-3 and Bm-cpl-6
transcript levels as determined by qRT-PCR (4worms per treatment
group); and (4) quantiﬁcation ofWolbachia using a sensitive quanti-
tative-PCR (qPCR) (Fenn and Blaxter, 2004; McGarry et al., 2004),
genomic DNA extracted from individual worms (3 worms per treat-
ment group), and the primers described in Supplementary Table 3.
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onic stages (eggs, embryos, pre-microﬁlariae, stretched microﬁlar-
iae) were counted following the method of Lok et al. (1988) with
small modiﬁcations. In brief, individual worms were transferred
into Eppendorf tubes containing 200 ll of PBS, and gently homog-
enized for 5–10 s using a disposable sterile pestle. The pestle was
washed with 300 ll of PBS and the ﬁnal volume of the homogenate
was then adjusted to 500 ll. The numbers for various embryonic
stages in the resulting suspension were determined microscopi-
cally (Nikon Eclipse E600) using a hemacytometer. More than
100 events were counted in each of two samples per worm. The
segmental data were added to get the total numbers per worm
for the different culturing conditions. The embryonic stages were
classiﬁed into 4 categories and the relative proportions of progeny
at different stages of development were then calculated.2.9. Statistical analysis
Comparisons between microﬁlariae release in the RNAi treated
groups were done using the two-tailed non-parametric Mann–
Whitney U-test. A P value of <0.05 was considered statistically
signiﬁcant.
Comparisons between the phenotypic outcomes in the RNAi
treated groups were done using the chi-square test for association
with a P value of <0.05 considered as statistically signiﬁcant for the
family of comparisons. P-values are provided for Bonferroni multi-
ple comparison adjustment. We utilized all available data, such
that there are two-worm and three-worm sets of analyses for the
48- and 96-hour experiments.3. Results
3.1. Depletion of Wolbachia by tetracycline treatment in vitro also
regulates the transcription of B. malayi cysteine proteases
The effect of Wolbachia depletion on the ﬁlarial Bm-cpl mRNA
expression was analyzed using qRT-PCR. The RNA was prepared
from groups of 4 adult female B. malayi worms cultured in vitro
in the presence or absence of tetracycline. Bm-cpl mRNA
expression was determined over the six day tetracycline treat-
ment. Notably, a bimodal expression pattern was observed. Bm-
cpl-3 and Bm-cpl-6 expression levels were signiﬁcantly higher on
day 1 with expression levels 16- and 47-fold higher, respectively,
as compared to the untreated worms (Fig. 1). By day 3, however,
Bm-cpl-3 and Bm-cpl-6 gene expression was down-regulated in
the treated worms as compared to the similarly cultured control
worms. The second expression peak was observed on day 6 of
the treatment: Bm-cpl-3 expression was 7-fold and Bm-cpl-6 17-
fold higher than controls (Fig. 1). In contrast, Bm-cpl-4 and
Bm-cpl-5 expression was not affected and remained unchanged
over the six days of treatment (Fig. 1).
In a previous study we found a similar gene regulation pattern
for four other genes belonging to the signal transduction pathway:
kinesin light chain protein 2 (WBGene00228531), phosphatase 2A
regulatory A subunit (Bm-paa-1 WBGene00233942), a protein
kinase (Bm-kin-3 WBGene00221966), and secretion associated
Ras-related COPII vesicle coat protein (Bma-sar-1
WBGene00233918) (Ghedin et al., 2009). We hypothesized that
this bimodal pattern of regulation is possibly associated with an
immediate effect (ﬁrst peak) of Wolbachia depletion on the B.
malayi pre-embryonic and embryonic stages, which appear to be
more sensitive to the death of the endosymbiont. While the second
peak is possibly associated with a delayed response to the elimina-
tion of the endosymbiont within the hypodermal tissues of the
adult worms (Ghedin et al., 2009). Consequently, we decided toinvestigate the dependency of gene expression regulation in differ-
ent B. malayi life stages: young unfertile female worms (42 days
post infection), and embryonic stages within the gonads, described
as eggs and embryos (EE). Both stages were treated with tetracy-
cline for six days in vitro. The mRNA isolated from samples cultured
for one or six days was transcribed into cDNA using random prim-
ers and the expression proﬁles of the Bm-cpl genes were recorded
using qRT-PCR (Fig. 2).
As expected, tetracycline treatment of eggs and embryos (EE)
resulted in the up-regulation on day 1 of Bm-cpl-3 and Bm-cpl-6
transcript expressions, 4-fold and 12-fold respectively. However,
both were down-regulated on day 6 when compared to their levels
on day 1—more than 103-fold for Bm-cpl-3 and 8 fold for Bm-cpl-
6—which probably reﬂected the consequent death of the EE due
to treatment, as previously hypothesized (Ghedin et al., 2009). In
the young unfertile female worms the expression of the Bm-cpl-3
was not affected on day 1 or day 6 (2.6 and 0.99 fold increase,
respectively), while Bm-cpl-6 was only up-regulated at day 6 (16
fold increase). In comparison, in fertile female adult worms both
transcripts were highly up-regulated at both time points after
treatment. In contrast, the expression proﬁle of Bm-cpl-4 and Bm-
cpl-5 did not show differential regulation in the different B. malayi
life stages. These data support the hypothesis that the bimodal
regulation of Bm-cpl-3 and -6 cysteine proteases of subgroup Ic is
related to the differential effect of tetracycline treatment on
Wolbachia in different tissues.
To conﬁrm that the regulation of these two cysteine proteases
has to do with the ﬁtness ofWolbachia, we analyzed the regulation
of the orthologous transcripts in the Wolbachia free rodent
ﬁlarial parasite A. viteae. The orthologous A. viteae cathepsin
L- like proteins were predicted based on the recently publically
available genome (http://nematodes.org/genomes/acanthocheilo-
nema_viteae/). As a ﬁrst step in this process, the A. viteae genes
were assigned to the various clades by phylogenetic analyses
(Fig. 3). This analysis recapitulates the topology of the tree pre-
sented in Guiliano et al. (2004) in terms of CPL clades with ﬁlarial
membership, and relationships between CPL clades. The newly
identiﬁed A. viteae CPL-1, CPL-3, CPL-6 and CPL-8 cysteine prote-
ases branch with their corresponding orthologues in B. malayi, con-
ﬁrming their assignment to these clades.
Using primers designed to the coding regions of the A. viteae
transcripts (Supplementary Table 2), the regulation of Av-cpl-3,
Av-cpl-6 and Av-cpl-8 was analyzed (we could not identify homo-
logues of Bm-cpl-4 or Bm-cpl-5). The cDNA samples used for the
analyses were generously provided by Dr. Kenneth M. Pfarr,
University Clinic Bonn, Germany. They were prepared from female
A. viteae adult worms recovered from infected Meriones unguicula-
tus (Mongolian jird) that were treated orally for six weeks with
0.5% (w/v) tetracycline in drinking water or from untreated infected
jirds (Strubing et al., 2010). As seen in Fig. 4, Av-cpl-3 and Av-cpl-6
transcript levels were unaffected by tetracycline treatment.
3.2. Proﬁles of cathepsin L-like proteases life stage-speciﬁc expression
over the B. malayi lifecycle
To further understand the potential interrelationship between
Bm-cpl-3 and Bm-cpl-6 with Wolbachia, we compared their tran-
scriptional regulation over the different life stages of the B. malayi
lifecycle in comparison to that of the Ia family members of CPLs. As
shown in Fig. 5, the relative expression of the cysteine protease
genes varied considerably among the four developmental stages
analyzed: adult male, adult female, microﬁlaria and L3. Transcripts
from the adult male stage were used as the reference point in the
pair wise comparisons of the mRNA levels because embryo and
microﬁlaria transcripts are inherently a subset of the adult female












Fig. 4. Analysis of mRNA levels of the A. viteae cathepsin L-like lc gene family after
tetracycline treatment in vivo. The mRNA levels of Av-cpl-3, Av-cpl-6 and Av-cpl-8
were compared between treated worms collected 6 weeks after tetracycline
treatment and untreated age-match control worms; three biological replicates
were analyzed. The Ct values of the A. viteae cysteine protease genes were
normalized using geometrical median of the housekeeping Av-actin gene. The cut
offs of 2-fold increase and decrease are marked by solid black lines.
Fig. 5. Stage-speciﬁc B. malayi cpl gene expression. The Ct values of cysteine
protease genes were normalized using the geometric median of housekeeping
genes (tubulin and gst). The cpl mRNA levels in the different life stages of the
parasite were compared to adult male worms (AM) using the DDCt method.
Abbreviations: AM, adult male; AF, adult female; MF, microﬁlaria; and L3 – third-
stage larvae.
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Bm-cpl-5) of the cathepsin L-like cysteine proteases, in particular
in the L3s; higher levels expression of Bm-cpl-3 and Bm-cpl-6 had
in adult female and microﬁlaria and very little in L3s, while Bm-
cpl-4 and Bm-cpl-5 were highly expressed in all stages tested—
adult female, microﬁlaria and L3s—with highest expression in L3s.
3.3. Subcellular immunolocalization of the B. malayi native Bm-CPL-3
and Bm-CPL-6 proteins by immunoelectron microscopy
Two speciﬁc polyclonal antibodies generated against the Bm-
CPL-3 and Bm-CPL-6 recombinant proteins were used to identify
the corresponding native CPL proteins in B. malayi. The endogenous
native proteins were localized by immunoelectron microscopy on
sections prepared from the different life-cycle stages of B. malayi.
The anti-Bm-CPL-3 antibodies reacted speciﬁcally with Wolbachia
and the area within the hypodermis in the adult female worm sur-
rounding the Wolbachia (Fig. 6a). Notably, there was no labeling of
the region of the hypodermis below the cuticle, where anti-Bm-
CPL-4 and -5 are present (Guiliano et al., 2004). In sections of
microﬁlaria, the Bm-CPL-3 was localized within the inner bodies
(Fig. 6c). The antibodies raised against Bm-CPL-6 reacted similarly
with Wolbachia and the area within the hypodermis in the adult
female worm surrounding the Wolbachia (Fig. 6b). In microﬁlaria
these antibodies labeled the protein in the cuticle and inner bodies
(Fig. 6d). Pre-immune sera did not cross-react with any proteins in
the sections of the life-cycle stages of B. malayi. An example of a
region containing Wolbachia within the hypodermis of adult
female worms is shown in Fig. 6e.
3.4. RNAi-mediated silencing of B. malayi Bm-cpl-3 and Bm-cpl-6
resulted in the reduction of microﬁlariae production in vitro and
within the uterus, as well as in the reduction of Wolbachia density
within each worm
To further determine the possible function(s) of the B. malayi
Bm-cpl-3 and Bm-cpl-6 cathepsin-like cysteine proteases during
embryogenesis, RNAi that selectively interferes with their expres-
sion was carried out. Release of microﬁlaria per female worm
was determined prior to siRNA treatment to provide a baseline
reading, showing that in the 4 worm groups the counts were
evenly distributed (Fig. 7a). Release of microﬁlariae from individ-
ual worms cultured for 48 h or 96 h in control conditions or treated
with 5 lM Bm-cpl-3 and Bm-cpl-6 siRNA was also determined. In
comparison to the media control and Ov-cpz-int2 siRNA control, a
signiﬁcant reduction in the number of microﬁlariae released intothe culture medium was observed in the Bm-cpl-3 and Bm-cpl-6
siRNA treated worms: 32.5% (Bm-cpl-3) and 39.7% (Bm-cpl-6)
reduction after 48 h RNAi treatment, and 55.7% (Bm-cpl-3) and
41.6% (Bm-cpl-6) reduction after 96 h RNAi treatment (Fig. 7b
and c).
Subsequently, we also analyzed the effect of the siRNA treat-
ment on embryogenesis. RNAi treatment with Bm-cpl-3 and
Bm-cpl-6 siRNA had dramatic effects on intrauterine embryogram
proﬁles (Table 1). Intrauterine progeny were examined 48 and 96
hours after RNAi treatment and expressed as the relative
proportions of progeny at different stages of development: eggs,
developing embryos, pre-microﬁlariae (pre-Mf) and Mf (Fig. 8). In
comparison to the percentage of intrauterine Mf in the medium
control (27.1% and 23.6% at 48 h and 96 h, respectively), the adult
female worms treated with Bm-cpl-3 and Bm-cpl-6 siRNA showed
signiﬁcant reductions in the number of intrauterine Mf in the
Bm-cpl-3 and Bm-cpl-6 siRNA treated worms: 67.5% and 45% reduc-
tion after 48 h, and 41.1% and 59.7% reduction 96 h after RNAi
treatment, respectively. When the percentage of intrauterine Mf
Fig. 6. Localization of the Ic members of the B. malayi cathepsin L-like cysteine proteases. (a) Bm-CPL-3 labeling in adult female worms. (b) Bm-CPL-6 labeling in adult female
worms. (c) Bm-CPL-3 labeling in puriﬁed microﬁlariae. (d) Bm-CPL-6 labeling in puriﬁed microﬁlariae. (e) NRS control. w =Wolbachia; n = nucleus; m = mitochondria;
ib = inner body. The bar is 500 nm.
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31.5% at 48 h and 96 h, respectively), signiﬁcant reductions were
also observed in the Bm-cpl-3 and Bm-cpl-6 siRNA treated worms:
57.7% and 35.3% reduction after 48 h, and 63.8% and 61.5% reduc-
tion 96 h after RNAi treatment, respectively. While the numbers
of Mf were reduced, the percentage of pre-Mf was signiﬁcantly
increased 48 h after RNAi in comparison to medium control
(8.4%): 251.1% in the Bm-cpl-3 and 515.5% in the Bm-cpl-6 siRNA
treated worms. This increase, however, was less apparent when
the percentage of the pre-Mf in the Bm-cpl-3 and Bm-cpl-6 siRNA
treated worms was compared to Ov-cpz-int2 (22.7%); 30.3% and
125.1% increase, respectively. The signiﬁcant increase in the per-
centage of pre-Mf was also observed 96 h post siRNA treatment
when compared to medium control (14.8%); 216.2% in the Bm-
cpl-3 and 260.8% in the Bm-cpl-6 RNAi treated worms. Similarly,
a signiﬁcant increase in the percentage of pre-Mf was observed
when it was compared to the RNAi negative control, Ov-cpz-int2
(10.2%); 346% in the Bm-cpl-3 and 380.4% in the Bm-cpl-6 RNAi
treated worms. The percentages of embryos and eggs were also
signiﬁcantly decreased in the Bm-cpl-3 and Bm-cpl-6 siRNA treated
worms 48 h or 96 h after RNAi treatment.
Importantly, when theWolbachia levels were measured by DNA
qPCR in the Bm-cpl-3 and Bm-cpl-6 siRNA treated worms, it
appeared that in comparison to worms cultured in medium alone
or in the presence of negative control siRNA (Ov-cpz-int2), the den-
sity of Wolbachia was moderately reduced 48 h after Bm-cpl-3 and
Bm-cpl-6 siRNA treatment: 20.2% and 20.8%, respectively, in com-
parison to media control, or 31.0% and 31.6%, respectively, when
compared with negative siRNA control (data not shown). Thereduction was much more signiﬁcant after 96 h of Bm-cpl-3 and
Bm-cpl-6 siRNA treatment: 92.6% and 89.5%, respectively, in com-
parison to media control, and 82.4% and 75%, respectively, when
compared with the negative siRNA control (Fig. 9). The Bm-cpl-3
and Bm-cpl-6 levels were reduced by 90% and 45%, respectively,
96 h after treatment when compared to the siRNA negative control
as determined by qRT-PCR (data not shown).4. Discussion
In this study we characterized in more detail the interrelation-
ship between the expression levels of the B. malayi Bm-cpl-3 and
Bm-cpl-6 cysteine proteases and the ﬁtness of Wolbachia, and con-
sequently that of the parasite. Our present in vitro data support our
previous in vivo studies showing that killingWolbachia using tetra-
cycline treatment of B. malayi worms resulted in differential
expression of these two enzymes (Ghedin et al., 2009). In contrast
to B. malayi, tetracycline treatment of A. viteae, which lacks a
Wolbachia endosymbiont, did not affect the expression of these
enzymes. That being said, the comparison of cpl expression in B.
malayi worms cultured for 6 days in vitro in the presence of tetra-
cycline with A. viteae, which were recovered from jirds after six
weeks of treatment with 0.5% (w/v) tetracycline in drinking water
(Strubing et al., 2010) was not optimal. However, six weeks of sim-
ilar oral tetracycline treatment of Litomosoides sigmodontis-
infected jirds has been shown to lead to a persistent depletion of
Wolbachia, demonstrating sufﬁcient tetracycline delivery with this
treatment (Arumugam et al., 2008). In contrast, similar tetracycline








































































Fig. 7. RNAi treatment of adult female B. malayi with Bm-cpl-3 and Bm-cpl-6 siRNA
leads to a reduction in microﬁlaria release from B. malayi in vitro. Following 24 h
culture in normal culture medium B. malayi female worms (one worm per well, nine
worms per group) were treated for 48 h and 96 h with 5 lM siRNA corresponding to
Bm-cpl-3, Bm-cpl-6 or negative control (Ov-cpz-Int2), or cultured in medium alone
(Control). Released microﬁlariae were collected and counted. Results are expressed
as microﬁlaria (mf) release before siRNA treatment (A), 48 h (B) and 96 h (C) after
treatment. Each graph represents one experiment, which is representative of at
least 3 separate experiments. P values denote a signiﬁcant difference between
dsRNA-treated worms and either untreated medium controls or negative control
(Ov-cpz-Int2) (Mann–Whitney U-test).
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show any phenotypic effects on the worm (Hoerauf et al., 1999).
In our previous studies we have shown that treatment of B. malayi
in vitro with 40 lg/ml tetracycline caused 100% degradation of
Wolbachia by day 5 without affecting the worms’ motility
(Ghedin et al., 2009).
The in vitro studies support our previous observations of a
bimodal expression pattern of B. malayi transcripts after tetracy-
cline treatment, including the two enzymes we studied here. We
hypothesize that this bimodal expression may be due to stage-
speciﬁc responses of the host in response to Wolbachia death; the
ﬁrst effect is in the pre-embryonic and embryonic stages of the
worms and the later effect is due to reduced ﬁtness of the worms.The differential expression patterns in female worms at various
stages of fertility were not surprising because adult female worms
(>70 days after infection) can produce eggs and contain developing
embryonic stages, which would account for the differential expres-
sion proﬁles in comparison to those in unfertile females. Clinical
studies in humans have also shown that in ﬁlaria-infected patients
treated with antibiotics the ﬁrst phenotype is reduction in the lev-
els of microﬁlariae followed by a long-term sterility and eventual
death of adult worms (Taylor et al., 2010).
However, it is possible that some of the responses observed
upon tetracycline treatment may also be unrelated to its anti-
bacterial effects. Tetracycline is known to have pleiotropic effects
that are unrelated to its antibiotic activity. For example, bacterio-
logically inactive analogs of tetracycline have been shown to inhi-
bit molting in B. malayi larvae, suggesting that the effect on
molting observed in tetracycline treated larvae is not related to
its anti-Wolbachia activity (Rajan, 2004). Similarly, tetracycline
has been shown to exhibit anti-collagenase activity, an enzymatic
activity that is likely important in molting, as collagens are an
important component of the parasite cuticle (Grifﬁn et al., 2010).
Dissection of the exact mechanism of the effect of tetracycline on
adult worms will require additional studies utilizing bacteriologi-
cally inactive analogs in addition to tetracycline, perhaps coupled
with RNAi studies that speciﬁcally target the enzymes in question
in parallel of both B. malayi and A. viteae worms.
To better understand the possible functions of the Ic cysteine
proteases in B. malayi, we analyzed the localization of these pro-
teins. Contrary to what was observed for cathepsin L-like cysteine
proteases in the Ia group (Guiliano et al., 2004), the proteins in the
Ic group were not localized to the hypodermal lamellae or the egg-
shell surrounding all stages of the developing microﬁlariae. They
were instead found in the inner bodies of microﬁlariae and co-
localized with Wolbachia. In some cases, they were found within
theWolbachia cells. As for our qRT-PCR analysis, RNAseq transcrip-
tome analysis of B. malayi stages (Choi et al., 2011) indicate that
Bm-cpl-3 is speciﬁcally up-regulated in immature microﬁlariae
while Bm-cpl-6 is up-regulated in both immature and mature
microﬁlariae. However, Bm- cpl-1, Bm-cpl-4 and Bm-cpl-5 are up-
regulated in the L3 stage, further indicating their potential differing
roles during development of the parasite. Our work supports the
hypothesis that there is tissue-speciﬁc differential regulation of
CPL gene expression in B. malayi.
To better understand Wolbachia’s dependence on these
enzymes, RNAi experiments targeting these transcripts will be
required to examine the consequences of their down-regulation
on Wolbachia in the different tissues of the parasite. Initial studies
have shown that decreases in Bm-cpl-3 and Bm-cpl-6 transcript lev-
els after 96hr of siRNA treatment resulted in a signiﬁcant reduction
ofWolbachia in the Bm-cpl-3 and Bm-cpl-6 siRNA treated worms. It
was also accompanied by a signiﬁcant reduction in the number of
microﬁlariae produced within the uteri of the treated female
worms and in the number of microﬁlaria released into the culture
medium. This supports our hypothesis that there is a deﬁnite link
between the Bm-CPL-3 and Bm-CPL-6 enzymes andWolbachia. This
link might be directly or, more likely, indirectly involved in the
maintenance of the symbiotic relationship and, consequently,
proper embryonic development leading to the release of stretch
microﬁlaria. The mechanism mediating this effect is still unknown.
One possible indirect biochemical link may be secondary: for
example, these enzymes may be used by Wolbachia for amino acid
provisioning as genome analysis of Wolbachia has shown that they
lack the capability for amino acid biosynthesis (Foster et al.,
2005a).
Further characterization of the Bm-CPL-3 and -6 function(s)
may lead to an improved understanding of ﬁlarial nematode
biology and identify these proteases as anti-ﬁlarial drug targets.
Table 1
Effects on embryogenesis after siRNA treatment of adult female B. malayi.
Intrauterine progeny* % Progeny 48 h after siRNA treatment (n = 3 per
group)
% Progeny 96 h after siRNA treatment (n = 2 per
group)
Control Bm-cpl-3 Bm-cpl-6 Control Bm-cpl-3 Bm-cpl-6
mf 27.1 8.8 14.9 23.6 13.9 9.5
pmf 8.4 29.5 51.7 14.8 46.8 53.4
emb 36.7 45.6 24.2 39.8 32.2 26.3
eggs 27.9 16.0 9.2 21.8 7.1 10.8
Intrauterine progeny* % Progeny 48 h after siRNA treatment (n = 2 per group) % Progeny 96 h after siRNA treatment (n = 3 per group)
Ov-cpz-Int2 Bm-cpl-3 Bm-cpl-6 Ov-cpz-Int2 Bm-cpl-3 Bm-cpl-6
mf 23.2 9.8 15.0 31.5 11.4 12.1
pmf 22.7 29.6 51.1 10.2 45.5 49.0
emb 43.9 43.8 24.6 43.3 34.8 27.8
eggs 10.3 16.9 9.3 15.1 8.3 11.1
Chi-square P-value of <0.001 were obtained for the treated and control groups and for the treated and Ov-cpz-int2 siRNA control groups at both 48 h and 96 h.
* Expressed as the relative proportions of progeny at different stages of development (see Fig. 8).
Fig. 8. Embryonic stages of development within a normal uterine of B. malayi female worm. Images of eggs, embryos, pre-microﬁlaria (pre-Mf) and stretched microﬁlaria
found in a normal uterine of B. malayi female worm are presented. These stages correspond to the stages counted when an embryogram is performed and as presented in
Table 1, where the effects of siRNA treatment on embryogenesis are reported. The images of eggs, pre-microﬁlaria (pre-Mf) and stretched microﬁlaria were taken using a 20 X






























Compared to control media (n=3) Compared to Ov-cpz-Int2 siRNA (n=3)
Fig. 9. RNAi treatment of B. malayi adult female worms with Bm-cpl-3 and Bm-cpl-6 siRNA results in signiﬁcant reduction ofWolbachia density. At the end of the experiment
(96 h after treatment), groups of three adult female worms were removed from each of the culture conditions. Total genomic DNA was extracted from individual worms, and
single copy genes from the Wolbachia genome (wsp) and the B. malayi (gst) nuclear genome were ampliﬁed. The PCR products were quantiﬁed in real time through
incorporation of SYBR green dye using an ABI 7300 Real-time PCR system calibrated with standard dilutions of control DNA targets. The ratio ofWolbachia gene copy number
to B. malayi gene copy number (wsp/gst ratio) per sample was then calculated. The percent reduction (mean ± SD) in the number ofWolbachia genomes per worm (n = 3) were
determined based on the wsp/gst ratio found in the worms that were cultured with media control or in worms that were treated with Ov-cpz-Int2 siRNA.
276 S. Lustigman et al. / International Journal for Parasitology: Drugs and Drug Resistance 4 (2014) 267–277Cysteine proteases are known to have essential functions in a
variety of parasitic systems, including other nematodes, and are
being developed as potential targets for drugs and vaccines
(McKerrow, 1999; Newton and Meeusen, 2003; Sajid et al., 2011;
Marco and Coteron, 2012; Vermeire et al., 2012).
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